Overview
The September 7 scan recorded 102 total 20-week breakout signals — 58 bullish (dollar_20_wk + pct_20_wk) versus 44 bearish (dollar_d20_wk + pct_d20_wk), a 56.9%/43.1% split. This places the tape in the Balanced zone (40-70% bullish), signaling mixed institutional sentiment rather than aggressive accumulation. With SA Regime reading Cautious and breadth at just 49.9% of stocks above their SMA-40, upside participation remains narrow even as headline sentiment reads Bullish/Neutral.
Sector leadership is rotating into defensive-growth hybrids: Energy (2.5% ATR%), Health Care (2.0%) and Communication Services (1.3%) lead, while Industrials, Real Estate and Utilities lag with negative ATR%. Notably, every ticker in today’s scan shows 0 institutional funds reporting — a red flag suggesting these are technical/momentum-driven breakouts rather than confirmed institutional accumulation.
Quality Score: 2/5. The Cautious regime caps conviction, and with zero institutional fund confirmation across all top movers, only the highest-volume, highest-relative-volume setups (BLTE, BE) merit tactical attention. Selectivity is paramount; this is not an environment for chasing broad breakout lists.
Top 5 Bullish Picks
BWET ($505.17) — ETF/ETN/CEF, Finance-ETF/ETN
Weekly Momentum: BWET posted an extreme dollar breakout with an 11.22x ATR multiple and ADR% of 6.7%, though relative volume is soft at 0.7x average. The 3737.1% distance from 52-week low reflects a leveraged/derivative product structure, not organic price discovery — treat with caution given the outsized LOD Risk ATR% of 40.0%.
| Level | Price |
|---|---|
| Current | $505.17 |
| Risk (1x ATR) | $474.18 |
| Target (2x ATR) | $567.15 |
Institutional Interest: 0 funds reporting; bucket data unavailable. Speculative, momentum-only setup.
BLTE ($193.61) — Medical, Development Biotech
Weekly Momentum: BLTE is the standout volume story — relative volume of 3.9x average (738,953 vs 190,080 avg) drove a 5.38x ATR breakout. Trading just -3.2% off its 52-week high with a massive 202.5% gain from its low, this early-stage biotech (bucket_0_youth_ipo) is showing genuine institutional-style volume confirmation despite the 0-fund reading.
| Level | Price |
|---|---|
| Current | $193.61 |
| Risk (1x ATR) | $185.56 |
| Target (2x ATR) | $209.71 |
Institutional Interest: 0 funds; bucket_0_youth_ipo_less_5yrs. High-conviction volume setup — best risk/reward in today’s list.
DAVE ($380.69) — Business Services, Computer-Tech Services
Weekly Momentum: DAVE’s breakout carries a modest 0.10x ATR multiple with light 0.6x relative volume, suggesting the dollar move is a slow grind rather than a sharp thrust. Still up 150.1% from its 52-week low, the growth_250 bucket placement confirms high-growth positioning, though the -16.9% gap from 52-week high shows room to run before overhead resistance.
| Level | Price |
|---|---|
| Current | $380.69 |
| Risk (1x ATR) | $357.61 |
| Target (2x ATR) | $426.85 |
Institutional Interest: 0 funds; growth_250 bucket. Watch for volume confirmation before adding size.
MELI ($1978.36) — Retail, Retail-Internet
Weekly Momentum: MELI’s dollar breakout (2.03x ATR, 3.5% ADR%) reflects steady institutional-grade price action in Latin America’s dominant e-commerce name. Sitting -22.4% off 52-week highs but +32.3% above lows, this is a large-cap consolidation breakout rather than a speculative spike — relative volume at 0.6x suggests the move is orderly, not panic-driven.
| Level | Price |
|---|---|
| Current | $1,978.36 |
| Risk (1x ATR) | $1,915.11 |
| Target (2x ATR) | $2,104.86 |
Institutional Interest: 0 funds reporting; all_unique_bucket_1_stocks. Large-cap quality despite thin fund data.
ULTA ($564.12) — Retail, Retail-Specialty
Weekly Momentum: ULTA’s breakout (3.50x ATR multiple, 3.5% ADR%) reflects sector-relative strength within Retail even as broader consumer discretionary lags. The stock remains -21.1% below its 52-week high with 27.2% cushion above its low, and the funds_1000 bucket suggests broad institutional coverage universe eligibility.
| Level | Price |
|---|---|
| Current | $564.12 |
| Risk (1x ATR) | $545.48 |
| Target (2x ATR) | $601.40 |
Institutional Interest: 0 funds; funds_1000 bucket. Specialty retail leadership candidate.
Bearish Alerts
Five notable breakdowns highlight distribution in growth-sensitive software and platform names. BLK (-8.0% off 52W high, ATR multiple 1.34) shows finance-sector weakness despite low relative volume (0.6x). IDXX is the sharpest decliner, -30.5% off its 52-week high with a negative -1.30x ATR multiple, signaling accelerating medical-systems weakness. SNPS (-36.0% off high, -1.05x ATR, 1.6x relative volume) shows the heaviest volume-confirmed selling in the group — a software design name under real distribution pressure. NET and DASH round out the list with softer ATR multiples but still meaningful drawdowns of -16.0% and -25.8% from highs, respectively, both remaining well above 52-week lows (75.6% and 47.8%), suggesting pullbacks within longer uptrends rather than trend reversals.
Software and enterprise-tech names dominate the bearish list, aligning with the Industrials/Real Estate/Utilities weakness noted in the regime data — a broader rotation away from rate-sensitive and high-multiple growth sectors.
Sector Theme
Cross-sector momentum favors Energy, Health Care and Communication Services, consistent with today’s bullish leaders in Medical (BLTE, MCK) and Energy (CEG, BE). Retail shows a bifurcated picture — MELI and ULTA breaking out on the bullish side while DASH breaks down, indicating stock-specific rather than sector-wide strength. Software remains the clearest area of institutional distribution, with SNPS and NET both showing bearish signals amid sector-wide multiple compression.
Institutional Summary
No tickers in today’s scan reported active institutional fund counts above zero, limiting confirmation of accumulation. Bucket classifications provide the best available proxy: BLTE (bucket_0_youth_ipo_less_5yrs) and BE (all_unique_bucket_1_stocks) represent higher-growth-tier placements, while ULTA and MCK sit in the broader funds_1000 coverage bucket, implying wider institutional eligibility even without confirmed current-quarter buying. Given the Cautious regime and absent fund data, position sizing should remain conservative until fund-flow confirmation improves.